ASTH
What one share of Astrana Health holds
Services – Management Consulting Services
Astrana is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner.
Astrana Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $78.21 |
|---|---|
| Profit | $0.82 |
| Capex (buildings and equipment) | $0.27 |
| Free cash flow | $1.92 |
| Dividends | $0.04 |
| Cash and investments | $7.19 |
| Debt | $16.80 |
| Book value | $14.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $9.57 | −$1.49 | $0.05 | −$1.41 | — | −$0.06 |
| 2017 | $12.43 | $0.90 | $0.07 | $1.74 | — | $4.95 |
| 2018 | $13.71 | $0.29 | $0.03 | $0.64 | — | $5.22 |
| 2019 | $15.40 | $0.39 | $0.03 | $0.35 | — | $5.33 |
| 2020 | $18.35 | $1.01 | $0.03 | $1.20 | — | $7.83 |
| 2021 | $17.05 | $1.52 | $0.42 | $1.13 | — | $10.04 |
| 2022 | $25.09 | $0.99 | $0.50 | $1.30 | — | $11.65 |
| 2023 | $29.54 | $1.29 | $0.61 | $0.85 | — | $11.08 |
| 2024 | $42.41 | $0.90 | $0.17 | $0.92 | — | $14.87 |
| 2025 | $64.45 | $0.46 | $0.20 | $2.12 | — | $15.94 |